Skip to main content
Log in

Price Regulation, Industry Structure and Innovation

An International Comparison of Pharmaceutical Industries

  • Comparison of Pharmaceutical Industries
  • Pharmaco Economics
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

The home competitive environment has a powerful effect on companies — shaping skills, strategies, and performance outside the home environment. Government industrial policies, such as pharmaceutical pricing regulations, affect companies primarily through shaping the nature of the home environment. Successful competitive environments (such as the UK) exhibit higher average drug prices and an internal structure of prices that favour significant innovators, discourage minor products, and provide a shield against foreign competitors. Poor competitive environments (such as France) exhibit low average prices and an internal price structure that favours weak local companies producing imitative or minor products.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Thomas LG. Spare the rod and spoil the industry: vigorous competition and vigorous regulation promote global competitive advantage. New York University working paper. December 1990

    Google Scholar 

  • Thomas LG. Price regulation, industry structure, and innovation: an international comparison of pharmaceutical industries. Work in progress, 1991

    Google Scholar 

  • Chew R, Teeling-Smith G, Wells R. Pharmaceuticals in seven nations, Office of Health Economics, London, 1985

    Google Scholar 

  • Davis R, Thomas LG. Direct estimation of synergy: a new approach to the diversity—performance debate. New York University working paper, October, 1990

    Google Scholar 

  • Porter ME. The competitive advantage of nations, Free Press, New York, 1990

    Google Scholar 

  • Thomas LG. Regulation and firm size: FDA impacts on innovation. Rand Journal of Economics, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, L.G. Price Regulation, Industry Structure and Innovation. Pharmacoeconomics 1 (Suppl 1), 9–12 (1992). https://doi.org/10.2165/00019053-199200011-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199200011-00005

Keywords

Navigation